Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers.

Cancers (Basel) · 2020 · PMC7699975 · PMID 33233705

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

In fact, there has been a clear trend in recent years towards an increase in the percentage of patients diagnosed with localized NSCLC, from 16.6% in 1988 to 23.6% in 2015 (SEER database) [ 3 ].

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.